Physician profile
Daniel Steinberg
NPI 1134394398
$611,379.98
in general payments reported to CMS, 2019-2025
27 companies · $50K in 2025
The $50K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141K · 2020: $112K · 2021: $97K · 2022: $75K · 2023: $55K · 2024: $81K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $40K · Food and Beverage: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,721.88 |
| Travel and Lodging | $39,705.46 |
| Food and Beverage | $25,236.18 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $196,708.68 | 2019-2025 | Sentinel, General - Balloons, General - Vascular Access |
| Medtronic Vascular, INC. | $146,946.38 | 2019-2020 | |
| Medtronic, INC. | $122,055.27 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Endurant Iis |
| Abbott Laboratories | $50,360.16 | 2019-2025 | Navitor, Tendyne, Amplatzer Talisman |
| Shockwave Medical, INC | $26,925.09 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $25,975.08 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Evoque |
| Terumo Medical Corporation | $22,167.00 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $8,694.57 | 2019 | |
| Ancora Heart, INC. | $4,031.83 | 2021-2025 | Accucinch |
| Biotronik INC. | $2,164.37 | 2021-2022 | |
| Livanova USA, INC. | $1,660.02 | 2019 | |
| Teleflex LLC | $682.97 | 2023-2025 | Manta, Guideliner, Trapliner |
| Recor Medical INC | $652.48 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Angiodynamics, INC. | $493.69 | 2023-2025 | Angiovac, Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $405.81 | 2021-2025 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $378.96 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Savvywire |
| Abiomed | $258.74 | 2019-2025 | |
| Jenavalve Technology, INC. | $202.46 | 2021 | |
| Acist Medical Systems, INC. | $140.54 | 2025 | |
| Biosense Webster, INC. | $111.39 | 2021 | |
| Zimmer Biomet Holdings, INC. | $102.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $100.23 | 2020 | |
| Novartis Pharmaceuticals Corporation | $75.19 | 2025 | |
| Heartflow, INC. | $26.28 | 2021 | |
| Opsens INC. | $21.69 | 2021 | |
| Stryker Corporation | $20.84 | 2025 | Clottriever Bold Catheter |
| W. L. Gore & Associates, INC. | $17.28 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.